top of page
OUR PIPELINE

Publications & Presentations

Uniquity ERS 2025 Poster Thumbnail.png

European Respiratory Society (ERS) 2025

A Phase 1 Randomized, Double-Blind Study of Safety, Tolerability, Pharmacokinetics of Solrikitug in Healthy Participants  

Download Poster
mAB
We are actively expanding our immunology and inflammation pipeline, with a laser focus on therapeutics for indications with limited or no available treatments.
mAB
bottom of page